Form 4: Macrogenics CEO Koenig Acquires Shares Through RSU Vesting
SEC Form 4 Filing
Macrogenics CEO Scott Koenig acquired 42,329 shares of common stock on February 15, 2025, through the vesting of restricted stock units.
Summary
- On February 15, 2025, Scott Koenig, the President and CEO of Macrogenics Inc., acquired 42,329 shares of common stock.
- This acquisition resulted from the vesting of restricted stock units (RSUs).
- The RSUs convert into the company's stock on a one-for-one basis.
- Following the transaction, Koenig directly owns 777,415 shares of Macrogenics common stock.
- Koenig also owns 42,330 restricted stock units.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of insider transactions related to compensation. The vesting of RSUs is a planned event.
Positives
- The CEO's acquisition of shares through RSU vesting can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements, but it indicates that additional RSUs will vest in the future.
Industry Context
This type of filing is standard for corporate insiders and provides transparency into their transactions in the company's stock.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 02/15/2023 | Reporting person was granted 127,000 restricted stock units. |
| 02/15/2024 | 33% of the restricted stock units vested. |
| 02/15/2025 | Transaction date: 42,329 shares acquired through RSU vesting; 33% of the restricted stock units vested. |
| 02/19/2025 | Date of signature for the Form 4 filing. |
Keywords
Macrogenics, Scott Koenig, MGNX, restricted stock units, RSU, Form 4, beneficial ownership, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.